Kolexia
Janus Nicolas
Pharmacien
Hôpital Pitie Salpetriere
Paris, France
89 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Insuffisance rénale Insuffisance rénale chronique Maladies du rein Hypertension artérielle Défaillance rénale chronique Anémie Protéinurie Tumeurs du sein Fibrose systémique néphrogénique

Industries

Cirrina
1 collaboration(s)
Dernière en 2017
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

A Comparative Analysis of Chatgpt Vs Expert in Managing Anticancer Drug in Patients Renal Insufficiency
65th ASH Annual Meeting Abstracts   02 novembre 2023
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations.
International journal of clinical pharmacy   26 octobre 2023
2101P Bleeding Induced by ANtiCAncer drugs (BIANCA) used breast cancer
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1623P Drug-drug interactions with tyrosine kinase inhibitors
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Long-term use of tinzaparin for the treatment of cancer-associated thrombosis in clinical practice: Insights from the prospective TROPIQUE study.
Journal de medecine vasculaire   20 mai 2022
Efficacy and Safety of Tinzaparin in CAT Patients with Hematological Malignancy
Blood   23 novembre 2021
Renal toxicity of anticancer drugs.
Nephrologie & therapeutique   18 novembre 2021
Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   06 octobre 2021
Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?
Cancers   09 avril 2020
Non-iodinated contrast media nephrotoxicity.
Nephrologie & therapeutique   06 octobre 2018